Crossmark

Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer

Crossref DOI link: https://doi.org/10.1007/s00345-023-04469-x

Published Online: 2023-06-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vanneste, Matthias https://orcid.org/0000-0003-4864-8706
van der Heij, Bart

Christiaansen, Charlotte Elisabeth

Berendsen, Chris L.

Driessen, Elisabeth Johanna Margaretha

Bruins, Harman Maxim
License Information

Text and Data Mining valid from 2023-06-17

Version of Record valid from 2023-06-17
More Information

Article History

Received: 23 February 2023

Accepted: 26 May 2023

First Online: 17 June 2023

Declarations

:

: The authors have no conflicts of interest to disclose.

: The study protocol was reviewed and approved by the hospital’s medical ethical committee METCZ (‘<i>’Medisch Ethische ToetsingsCommissie van Zuyderland’’</i>) under registration number METCZ20220074. All procedures used in this study adhere to the principles of the Declaration of Helsinki.

: The need for individual patient’s informed consent was waived by the hospital’s medical ethical committee in view of the retrospective nature of the study, the processing of only anonymous data and all procedures being part of the routine care.

Document is current

Any future updates will be listed below